Phreesia, Inc. (NYSE:PHR) SVP David Linetsky Sells 11,853 Shares

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,853 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $24.85, for a total value of $294,547.05. Following the transaction, the senior vice president now directly owns 188,354 shares of the company’s stock, valued at approximately $4,680,596.90. This trade represents a 5.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

David Linetsky also recently made the following trade(s):

• On Friday, October 18th, David Linetsky sold 1,100 shares of Phreesia stock. The shares were sold at an average price of $20.49, for a total value of $22,539.00.
• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $24.04, for a total value of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The stock was sold at an average price of $24.77, for a total value of $891.72.

Phreesia Trading Up 1.6 %

PHR opened at $24.94 on Friday. The business has a 50 day simple moving average of $20.45 and a two-hundred day simple moving average of $21.82. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of -16.97 and a beta of 0.98. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.58) EPS. Analysts predict that Phreesia, Inc. will post -1.22 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on PHR shares. Robert W. Baird reduced their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 target price on shares of Phreesia in a research report on Friday, September 27th. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Tuesday. JPMorgan Chase & Co. boosted their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, September 9th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $29.33.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Trust Point Inc. grew its stake in shares of Phreesia by 3.5% in the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after buying an additional 607 shares during the last quarter. Ensign Peak Advisors Inc grew its stake in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after buying an additional 700 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after buying an additional 853 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock worth $637,000 after buying an additional 905 shares during the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock worth $701,000 after buying an additional 1,120 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.